Ingredion (INGR) Misses Q4 EPS by 20c

Ingredion (NYSE: INGR) reported Q4 EPS of $1.09, $0.20 worse than the analyst estimate of $1.29. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.72 billion.

GUIDANCE:

Ingredion sees FY2022 EPS of $6.85-$7.45, versus the consensus of $7.41.

For earnings history and earnings-related data on Ingredion (INGR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79